Skip to main content
Erschienen in: Journal of General Internal Medicine 10/2019

11.06.2019

Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial

verfasst von: Derek D. Satre, Ph.D., Amy S. Leibowitz, Psy.D., Wendy Leyden, M.P.H, Sheryl L. Catz, Ph.D., C. Bradley Hare, M.D., Hannah Jang, Ph.D., Jennifer O. Lam, Ph.D., Kendall J. Bryant, Ph.D., Constance M. Weisner, Dr.P.H., MSW, Stacy A. Sterling, Dr.P.H., Michael Horberg, M.D., Paul Volberding, M.D., Michael J. Silverberg, Ph.D., M.P.H.

Erschienen in: Journal of General Internal Medicine | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Unhealthy alcohol use has adverse effects on HIV treatment. Screening, brief intervention, and referral to treatment (SBIRT) has some evidence of efficacy but may not be sufficient for those with low motivation or comorbid substance use.

Objective

To examine the effectiveness of motivational interviewing (MI) and emailed feedback (EF) among primary care HIV-positive patients, compared with treatment as usual care (UC) only, which included SBIRT.

Design

Randomized clinical trial.

Participants

Six hundred fourteen adult HIV-positive patients in Kaiser Permanente Northern California who reported prior-year unhealthy alcohol use.

Intervention

Participants were randomized to either three sessions of MI (one in person and two by phone), information regarding alcohol risks via EF through a patient portal, or UC alone. MI and EF participants who reported unhealthy alcohol use at 6 months were offered additional MI and EF treatment, respectively.

Main Measures

Participant-reported unhealthy alcohol use (defined as ≥ 4/≥ 5 drinks per day for women/men), alcohol problems at 12 months, based on blinded telephone interviews. Secondary outcomes included drug use and antiretroviral (ART) adherence.

Key Results

At 12 months, there were no overall group differences, but in all three arms, there were declines in unhealthy alcohol use and alcohol-related problems (p < 0.001). Participants reporting low motivation to reduce drinking at baseline were less likely to report unhealthy alcohol use if they received MI vs. EF and UC (p = 0.013). At 6 months, reported illegal drug use/misuse of prescription drugs other than marijuana was lower in the MI arm than EF or UC (p = 0.012). There were no differences in ART adherence between groups.

Conclusions

In a randomized trial of HIV-positive patients using two behavioral interventions compared with SBIRT alone, participants in all three conditions reduced unhealthy alcohol use. MI may provide added benefit for patients with low motivation or who report illegal drug use/misuse of prescription drugs.

Trial Registration

NCT01671501 (ClinicalTrials.​gov)
Literatur
1.
Zurück zum Zitat Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and factors associated with hazardous alcohol use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav 2017;21(7):1914–25.PubMedPubMedCentralCrossRef Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and factors associated with hazardous alcohol use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav 2017;21(7):1914–25.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Marshall BD, Operario D, Bryant KJ, Cook RL, Edelman EJ, Gaither JR, et al. Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans. Drug Alcohol Depend 2015;148:69–76.CrossRefPubMed Marshall BD, Operario D, Bryant KJ, Cook RL, Edelman EJ, Gaither JR, et al. Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans. Drug Alcohol Depend 2015;148:69–76.CrossRefPubMed
3.
4.
Zurück zum Zitat Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend 2010;112(3):178–93.PubMedPubMedCentralCrossRef Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend 2010;112(3):178–93.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 2006;43(4):411–7.PubMedPubMedCentralCrossRef Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 2006;43(4):411–7.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Monroe AK, Lau B, Mugavero MJ, Mathews WC, Mayer KH, Napravnik S, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr 2016;73(4):419–25.PubMedPubMedCentralCrossRef Monroe AK, Lau B, Mugavero MJ, Mathews WC, Mayer KH, Napravnik S, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr 2016;73(4):419–25.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Sullivan LE, Goulet JL, Justice AC, Fiellin DA. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend 2011;117(2–3):158–63.PubMedPubMedCentralCrossRef Sullivan LE, Goulet JL, Justice AC, Fiellin DA. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend 2011;117(2–3):158–63.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Shuper PA, Joharchi N, Irving H, Rehm J. Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis. AIDS Behav 2009;13(6):1021–36.CrossRefPubMed Shuper PA, Joharchi N, Irving H, Rehm J. Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis. AIDS Behav 2009;13(6):1021–36.CrossRefPubMed
9.
Zurück zum Zitat Fairbairn NS, Walley AY, Cheng DM, Quinn E, Bridden C, Chaisson C, et al. Mortality in HIV-infected alcohol and drug users in St. Petersburg, Russia. PLoS One 2016;11(11):e0166539.PubMedPubMedCentralCrossRef Fairbairn NS, Walley AY, Cheng DM, Quinn E, Bridden C, Chaisson C, et al. Mortality in HIV-infected alcohol and drug users in St. Petersburg, Russia. PLoS One 2016;11(11):e0166539.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, et al. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: The ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract 2015;10(26):26.PubMedPubMedCentralCrossRef Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, et al. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: The ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract 2015;10(26):26.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Babor TF, Del Boca F, Bray JW. Screening, Brief Intervention and Referral to Treatment: implications of SAMHSA’s SBIRT initiative for substance abuse policy and practice. Addiction. 2017;112 Suppl 2:110–7.CrossRefPubMed Babor TF, Del Boca F, Bray JW. Screening, Brief Intervention and Referral to Treatment: implications of SAMHSA’s SBIRT initiative for substance abuse policy and practice. Addiction. 2017;112 Suppl 2:110–7.CrossRefPubMed
12.
Zurück zum Zitat DeLorenze GN, Satre DD, Quesenberry CP, Tsai AL, Weisner CM. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDs 2010;24(11):705–12.PubMedPubMedCentralCrossRef DeLorenze GN, Satre DD, Quesenberry CP, Tsai AL, Weisner CM. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDs 2010;24(11):705–12.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Williams EC, Lapham GT, Bobb JF, Rubinsky AD, Catz SL, Shortreed SM, et al. Documented brief intervention not associated with resolution of unhealthy alcohol use one year later among VA patients living with HIV. J Subst Abus Treat 2017;78:8–14.CrossRef Williams EC, Lapham GT, Bobb JF, Rubinsky AD, Catz SL, Shortreed SM, et al. Documented brief intervention not associated with resolution of unhealthy alcohol use one year later among VA patients living with HIV. J Subst Abus Treat 2017;78:8–14.CrossRef
14.
Zurück zum Zitat Satre DD, Leibowitz A, Sterling SA, Lu Y, Travis A, Weisner C. A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. J Consult Clin Psychol 2016;84(7):571–9.PubMedPubMedCentralCrossRef Satre DD, Leibowitz A, Sterling SA, Lu Y, Travis A, Weisner C. A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. J Consult Clin Psychol 2016;84(7):571–9.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Vasilaki EI, Hosier SG, Cox WM. The efficacy of motivational interviewing as a brief intervention for excessive drinking: A meta-analytic review. Alcohol Alcohol 2006;41(3):328–35.CrossRefPubMed Vasilaki EI, Hosier SG, Cox WM. The efficacy of motivational interviewing as a brief intervention for excessive drinking: A meta-analytic review. Alcohol Alcohol 2006;41(3):328–35.CrossRefPubMed
16.
Zurück zum Zitat Bendtsen P, Johansson K, Akerlind I. Feasibility of an email-based electronic screening and brief intervention (e-SBI) to college students in Sweden. Addict Behav 2006;31(5):777–87.CrossRefPubMed Bendtsen P, Johansson K, Akerlind I. Feasibility of an email-based electronic screening and brief intervention (e-SBI) to college students in Sweden. Addict Behav 2006;31(5):777–87.CrossRefPubMed
17.
Zurück zum Zitat Schwartz RP, Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, et al. Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial. Addiction. 2014;109(7):1091–8.PubMedPubMedCentralCrossRef Schwartz RP, Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, et al. Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial. Addiction. 2014;109(7):1091–8.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857–67.PubMedPubMedCentralCrossRef Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857–67.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Simon GE, Ralston JD, Savarino J, Pabiniak C, Wentzel C, Operskalski BH. Randomized trial of depression follow-up care by online messaging. J Gen Intern Med 2011;26(7):698–704.PubMedPubMedCentralCrossRef Simon GE, Ralston JD, Savarino J, Pabiniak C, Wentzel C, Operskalski BH. Randomized trial of depression follow-up care by online messaging. J Gen Intern Med 2011;26(7):698–704.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Kuerbis A, Armeli S, Muench F, Morgenstern J. Profiles of confidence and commitment to change as predictors of moderated drinking: a person-centered approach. Psychol Addict Behav 2014;28(4):1065–76.PubMedPubMedCentralCrossRef Kuerbis A, Armeli S, Muench F, Morgenstern J. Profiles of confidence and commitment to change as predictors of moderated drinking: a person-centered approach. Psychol Addict Behav 2014;28(4):1065–76.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat McCambridge J, Saitz R. Rethinking brief interventions for alcohol in general practice. BMJ. 2017;356:j116.CrossRefPubMed McCambridge J, Saitz R. Rethinking brief interventions for alcohol in general practice. BMJ. 2017;356:j116.CrossRefPubMed
22.
Zurück zum Zitat Jonas DE, Garbutt JC, Amick HR, Brown JM, Brownley KA, Council CL, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2012;157(9):645–54.CrossRefPubMed Jonas DE, Garbutt JC, Amick HR, Brown JM, Brownley KA, Council CL, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2012;157(9):645–54.CrossRefPubMed
23.
Zurück zum Zitat Satre DD, Mertens JR, Arean PA, Weisner C. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction. 2004;99(10):1286–97.CrossRefPubMed Satre DD, Mertens JR, Arean PA, Weisner C. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction. 2004;99(10):1286–97.CrossRefPubMed
24.
Zurück zum Zitat Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 2013;30(8):613–28.PubMedPubMedCentralCrossRef Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 2013;30(8):613–28.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Justice AC, McGinnis KA, Tate JP, Braithwaite RS, Bryant KJ, Cook RL, et al. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend 2016;161:95–103.PubMedPubMedCentralCrossRef Justice AC, McGinnis KA, Tate JP, Braithwaite RS, Bryant KJ, Cook RL, et al. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend 2016;161:95–103.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Silverberg MJ, Leyden WA, Leibowitz A, Hare CB, Jang HJ, Sterling S, et al. Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study. Addict Behav 2018;84:110–7.PubMedPubMedCentralCrossRef Silverberg MJ, Leyden WA, Leibowitz A, Hare CB, Jang HJ, Sterling S, et al. Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study. Addict Behav 2018;84:110–7.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abus Treat 1992;9(3):199–213.CrossRef McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abus Treat 1992;9(3):199–213.CrossRef
29.
Zurück zum Zitat Heather N, Smailes D, Cassidy P. Development of a Readiness Ruler for use with alcohol brief interventions. Drug Alcohol Depend 2008;98(3):235–40.CrossRefPubMed Heather N, Smailes D, Cassidy P. Development of a Readiness Ruler for use with alcohol brief interventions. Drug Alcohol Depend 2008;98(3):235–40.CrossRefPubMed
30.
Zurück zum Zitat Bertholet N, Gaume J, Faouzi M, Gmel G, Daeppen JB. Predictive value of readiness, importance, and confidence in ability to change drinking and smoking. BMC Public Health 2012;12:708.PubMedPubMedCentralCrossRef Bertholet N, Gaume J, Faouzi M, Gmel G, Daeppen JB. Predictive value of readiness, importance, and confidence in ability to change drinking and smoking. BMC Public Health 2012;12:708.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Simoni JM, Huh D, Wang Y, Wilson IB, Reynolds NR, Remien RH, et al. The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS Behav 2014;18(12):2285–90.PubMedPubMedCentralCrossRef Simoni JM, Huh D, Wang Y, Wilson IB, Reynolds NR, Remien RH, et al. The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS Behav 2014;18(12):2285–90.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Vinson DC, Kruse RL, Seale JP. Simplifying alcohol assessment: two questions to identify alcohol use disorders. Alcohol Clin Exp Res 2007;31(8):1392–8.CrossRefPubMed Vinson DC, Kruse RL, Seale JP. Simplifying alcohol assessment: two questions to identify alcohol use disorders. Alcohol Clin Exp Res 2007;31(8):1392–8.CrossRefPubMed
34.
Zurück zum Zitat Hulley SB, Newman TB, Cummings SR, Hearst N, Grady D, Browner WS. Designing Clinical Research: An Epidemiologic Approach. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. Hulley SB, Newman TB, Cummings SR, Hearst N, Grady D, Browner WS. Designing Clinical Research: An Epidemiologic Approach. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.
35.
Zurück zum Zitat Fleming MF, Balousek SL, Grossberg PM, Mundt MP, Brown D, Wiegel JR, et al. Brief physician advice for heavy drinking college students: a randomized controlled trial in college health clinics. J Stud Alcohol Drugs 2010;71(1):23–31.PubMedPubMedCentralCrossRef Fleming MF, Balousek SL, Grossberg PM, Mundt MP, Brown D, Wiegel JR, et al. Brief physician advice for heavy drinking college students: a randomized controlled trial in college health clinics. J Stud Alcohol Drugs 2010;71(1):23–31.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Satre DD, Delucchi K, Lichtmacher J, Sterling SA, Weisner C. Motivational interviewing to reduce hazardous drinking and drug use among depression patients. J Subst Abus Treat 2013;44(3):323–9.CrossRef Satre DD, Delucchi K, Lichtmacher J, Sterling SA, Weisner C. Motivational interviewing to reduce hazardous drinking and drug use among depression patients. J Subst Abus Treat 2013;44(3):323–9.CrossRef
37.
Zurück zum Zitat Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2013. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2013.
38.
Zurück zum Zitat National Institute on Alcohol Abuse and Alcoholism. Tips for cutting down on drinking. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism 2007. Report No.: NIH Publication No. 07–3769. National Institute on Alcohol Abuse and Alcoholism. Tips for cutting down on drinking. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism 2007. Report No.: NIH Publication No. 07–3769.
39.
Zurück zum Zitat Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001;96(12):1725–42.CrossRefPubMed Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001;96(12):1725–42.CrossRefPubMed
40.
Zurück zum Zitat Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Fiellin LE, et al. The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients. Contemp Clin Trials 2017;52:80–90.CrossRefPubMed Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Fiellin LE, et al. The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients. Contemp Clin Trials 2017;52:80–90.CrossRefPubMed
41.
Zurück zum Zitat Jaehne A, Loessl B, Frick K, Berner M, Hulse G, Balmford J. The efficacy of stepped care models involving psychosocial treatment of alcohol use disorders and nicotine dependence: a systematic review of the literature. Curr Drug Abuse Rev 2012. Jaehne A, Loessl B, Frick K, Berner M, Hulse G, Balmford J. The efficacy of stepped care models involving psychosocial treatment of alcohol use disorders and nicotine dependence: a systematic review of the literature. Curr Drug Abuse Rev 2012.
42.
Zurück zum Zitat Drummond C, Coulton S, James D, Godfrey C, Parrott S, Baxter J, et al. Effectiveness and cost-effectiveness of a stepped care intervention for alcohol use disorders in primary care: pilot study. Br J Psychiatry 2009;195(5):448–56.CrossRefPubMed Drummond C, Coulton S, James D, Godfrey C, Parrott S, Baxter J, et al. Effectiveness and cost-effectiveness of a stepped care intervention for alcohol use disorders in primary care: pilot study. Br J Psychiatry 2009;195(5):448–56.CrossRefPubMed
43.
Zurück zum Zitat Moyers TB, Martin T, Manuel JK, Miller WR, Ernst D. Revised Global Scales: Motivational Interviewing Treatment Integrity 3.1.1 (MITI 3.1.1). University of New Mexico: Center on Alcoholism, Substance Abuse and Addictions (CASAA), 2010. Moyers TB, Martin T, Manuel JK, Miller WR, Ernst D. Revised Global Scales: Motivational Interviewing Treatment Integrity 3.1.1 (MITI 3.1.1). University of New Mexico: Center on Alcoholism, Substance Abuse and Addictions (CASAA), 2010.
44.
Zurück zum Zitat Cohen BB, Vinson DC. Retrospective self-report of alcohol consumption: Test-retest reliability by telephone. Alcohol Clin Exp Res 1995;19(5):1156–61.CrossRefPubMed Cohen BB, Vinson DC. Retrospective self-report of alcohol consumption: Test-retest reliability by telephone. Alcohol Clin Exp Res 1995;19(5):1156–61.CrossRefPubMed
45.
Zurück zum Zitat Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. 2nd ed. New York: Oxford University Press; 2002. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. 2nd ed. New York: Oxford University Press; 2002.
46.
Zurück zum Zitat StataCorp. Stata Statistical Software: Release 12. College Station: StataCorp LP; 2011. StataCorp. Stata Statistical Software: Release 12. College Station: StataCorp LP; 2011.
47.
Zurück zum Zitat Saitz R, Palfai TP, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travaglini CA, et al. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–13.PubMedPubMedCentralCrossRef Saitz R, Palfai TP, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travaglini CA, et al. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–13.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Aharonovich E, Stohl M, Ellis J, Amrhein P, Hasin D. Commitment strength, alcohol dependence and HealthCall participation: effects on drinking reduction in HIV patients. Drug Alcohol Depend 2014;135:112–8.CrossRefPubMed Aharonovich E, Stohl M, Ellis J, Amrhein P, Hasin D. Commitment strength, alcohol dependence and HealthCall participation: effects on drinking reduction in HIV patients. Drug Alcohol Depend 2014;135:112–8.CrossRefPubMed
49.
Zurück zum Zitat Williams EC, Hahn JA, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol use and Human Immunodeficiency Virus (HIV) infection: current knowledge, implications, and future directions. Alcohol Clin Exp Res 2016;40(10):2056–72.PubMedPubMedCentralCrossRef Williams EC, Hahn JA, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol use and Human Immunodeficiency Virus (HIV) infection: current knowledge, implications, and future directions. Alcohol Clin Exp Res 2016;40(10):2056–72.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Scott-Sheldon LAJ, Carey KB, Johnson BT, Carey MP, Team MR. Behavioral interventions targeting alcohol use among people living with HIV/AIDS: A systematic review and meta-analysis. AIDS Behav 2017;21(Suppl 2):126–43.PubMedPubMedCentralCrossRef Scott-Sheldon LAJ, Carey KB, Johnson BT, Carey MP, Team MR. Behavioral interventions targeting alcohol use among people living with HIV/AIDS: A systematic review and meta-analysis. AIDS Behav 2017;21(Suppl 2):126–43.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, et al. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial. Addiction. 2017;112(6):1036–44.PubMedPubMedCentralCrossRef Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, et al. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial. Addiction. 2017;112(6):1036–44.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Kahler CW, Pantalone DW, Mastroleo NR, Liu T, Bove G, Ramratnam B, et al. Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial. J Consult Clin Psychol 2018;86(8):645–56.PubMedPubMedCentralCrossRef Kahler CW, Pantalone DW, Mastroleo NR, Liu T, Bove G, Ramratnam B, et al. Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial. J Consult Clin Psychol 2018;86(8):645–56.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010;5(6):e11068.PubMedPubMedCentralCrossRef Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010;5(6):e11068.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Meier E, Miller MB, Lombardi N, Leffingwell T. Assessment reactivity: A randomized controlled trial of alcohol-specific measures on alcohol-related behaviors. Addict Behav 2017;67:44–8.CrossRefPubMed Meier E, Miller MB, Lombardi N, Leffingwell T. Assessment reactivity: A randomized controlled trial of alcohol-specific measures on alcohol-related behaviors. Addict Behav 2017;67:44–8.CrossRefPubMed
Metadaten
Titel
Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial
verfasst von
Derek D. Satre, Ph.D.
Amy S. Leibowitz, Psy.D.
Wendy Leyden, M.P.H
Sheryl L. Catz, Ph.D.
C. Bradley Hare, M.D.
Hannah Jang, Ph.D.
Jennifer O. Lam, Ph.D.
Kendall J. Bryant, Ph.D.
Constance M. Weisner, Dr.P.H., MSW
Stacy A. Sterling, Dr.P.H.
Michael Horberg, M.D.
Paul Volberding, M.D.
Michael J. Silverberg, Ph.D., M.P.H.
Publikationsdatum
11.06.2019
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 10/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05065-9

Weitere Artikel der Ausgabe 10/2019

Journal of General Internal Medicine 10/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.